Literature DB >> 21093037

Renal sympathetic denervation: the jury is still out.

Michael Doumas1, Stella Douma.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 21093037     DOI： 10.1016/S0140-6736(10)62111-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Carotid baroreceptor activation for the treatment of resistant hypertension and heart failure.

Authors:  Michael Doumas; Charles Faselis; Costas Tsioufis; Vasilios Papademetriou
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

Review 2.  Renal sympathetic denervation: applications in hypertension and beyond.

Authors:  Michael Böhm; Dominik Linz; Daniel Urban; Felix Mahfoud; Christian Ukena
Journal:  Nat Rev Cardiol       Date:  2013-06-18       Impact factor: 32.419

3.  Can catheter-based renal denervation be used safely and effectively to substantially reduce blood pressure in treatment-resistant hypertensive patients?

Authors:  Suzanne Oparil
Journal:  Curr Cardiol Rep       Date:  2011-12       Impact factor: 2.931

Review 4.  Investing in high blood pressure research: a national institutes of health perspective.

Authors:  Zorina S Galis; Terry Thrasher; Diane M Reid; Dennis V Stanley; Young S Oh
Journal:  Hypertension       Date:  2013-02-25       Impact factor: 10.190

Review 5.  Non-interventional management of resistant hypertension.

Authors:  Michael Doumas; Costas Tsioufis; Charles Faselis; Antonios Lazaridis; Haris Grassos; Vasilios Papademetriou
Journal:  World J Cardiol       Date:  2014-10-26

6.  Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes?

Authors:  Michael Doumas; Konstantinos Stavropoulos; Konstantinos P Imprialos; Vasilios G Athyros; Asterios Karagiannis
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-25       Impact factor: 3.738

7.  Renal nerve ablation for resistant hypertension: the dust has not yet settled.

Authors:  Michael Doumas; Antonios Lazaridis; Vasilios Papademetriou
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-04-28       Impact factor: 3.738

8.  Drug-resistant hypertension: is renal sympathetic denervation the answer?

Authors:  Keith A Thompson; Saibal Kar; Raj Makkar; Ronald G Victor
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

Review 9.  Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.

Authors:  Thomas Unger; Ludovit Paulis; Domenic A Sica
Journal:  Eur Heart J       Date:  2011-09-27       Impact factor: 29.983

10.  Sympatho-renal axis in chronic disease.

Authors:  Paul A Sobotka; Felix Mahfoud; Markus P Schlaich; Uta C Hoppe; Michael Böhm; Henry Krum
Journal:  Clin Res Cardiol       Date:  2011-06-19       Impact factor: 5.460
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.